Charles L. Sprung

Overview

Best Publications

• Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

  Dellinger Rp;Levy Mm;Rhodes A;Annane D

  16672
  Citations

• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  R. Phillip Dellinger;Mitchell M. Levy;Andrew Rhodes;Djillali Annane

  12893
  Citations

• Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

  Laura Evans;Andrew Rhodes;Waleed Alhazzani;Massimo Antonelli

  7409
  Citations

• Multiple organ dysfunction score : a reliable descriptor of a complex clinical outcome

  John C. Marshall;Deborah J. Cook;Nicolas V. Christou;Gordon R. Bernard

  3910
  Citations

• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study

  Jl Vincent;A De Mendonca;F Cantraine;R Moreno

  3895
  Citations

• Sepsis in European intensive care units: results of the SOAP study.

  Jean-Louis Vincent;Yasser Sakr;Charles L. Sprung;V Marco Ranieri

  3692
  Citations

• Hydrocortisone Therapy for Patients with Septic Shock

  Charles L. Sprung;Djillali Annane;Didier Keh;Rui Moreno

  2568
  Citations

• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  Ziegler Ej;Fisher Cj;Sprung Cl;Straube Rc

  2293
  Citations

• End-of-life practices in European intensive care units: the Ethicus Study.

  Charles L. Sprung;Simon L. Cohen;Peter Sjokvist;Mario Baras

  1921
  Citations

• Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU.

  Judy E. Davidson;Rebecca A. Aslakson;Ann C. Long;Kathleen A. Puntillo

  1544
  Citations

• Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

  Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp

  1513
  Citations

• A look into the nature and causes of human errors in the intensive care unit

  Y Donchin;D Gopher;M Olin;Y Badihi

  1352
  Citations

• Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

  Edward Abraham;Konrad Reinhart;Steven Opal;Ignace Demeyer

  1252
  Citations

• High-dose corticosteroids in patients with the adult respiratory distress syndrome.

  G R Bernard;J M Luce;C L Sprung;J E Rinaldo

  1243
  Citations

• Clinical Antecedents to In-Hospital Cardiopulmonary Arrest

  Roland M.H. Schein;Nelson Hazday;Maria Pena;Bradley H. Ruben

  1220
  Citations

• The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study

  Rui Moreno;Jean Louis Vincent;Ricardo Tedeschi Matos;A. Mendonça

  1089
  Citations

• The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study.

  Charles L. Sprung;Charles L. Sprung;Panagiota V. Caralis;Eileen H. Marcial;Eileen H. Marcial;Margaret Pierce;Margaret Pierce

  1055
  Citations

• Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score.

  A. de Mendonça;J.-L. Vincent;P. M. Suter;R. Moreno

  1016
  Citations

• The ACCP-SCCM consensus conference on sepsis and organ failure.

  Roger C. Bone;William J. Sibbald;Charles L. Sprung

  977
  Citations

• Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.

  Paul E. Marik;Stephen M. Pastores;Djillali Annane;Gianfranco Meduri

  864
  Citations